EUVIMEDEUVIMED entdecken
Crossref

CD271 Targeted Near-Infrared Photoimmunotherapy for Local Depletion of Cancer Stem Cells

Ryosuke Takahashi iD, Atsushi Kaida, Hitomi Nojima, Shuhei Okuyama, Mai Mochizuki, Shinkichi Morita, Keiichi Tamai, Masahiko Miura, Hisataka Kobayashi iD, Takahiro Asakage, Ryuhei Okada iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c01157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Ryosuke Takahashi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, Institute of Science Tokyo, Tokyo 113-8519, Japan. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Immunotherapy, Receptors, Nerve Growth Factor, Head and Neck Neoplasms. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Intramural Research Program, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer stem cells have the ability to self-renew and show resistance to conventional drug therapy and radiation therapy, potentially resulting in cancer recurrence and metastasis. Since inadequate treatment of cancer stem cells can cause local recurrence and metastasis, an important goal of cancer therapy is to target these cancer stem cells. Near-infrared photoimmunotherapy (NIR-PIT) is one of the cell-selective cancer treatments. Cancer stem cell can be locally depleted by NIR-PIT using appropriate antibody-photoabsorber (IR700) conjugates (APCs). In this study, the efficacy of NIR-PIT against CD271, which has been reported as a marker of cancer stem cells in various cancers, including head and neck cancers, was confirmed using two different human head and neck cancer cell lines, HPCM2 and HSC-3. We demonstrated the efficacy of NIR-PIT against CD271 in both in vitro and in vivo experiments. The efficacy of CD271-targeted NIR-PIT was comparable to that of EGFR-targeted NIR-PIT in mouse models, even though the cell-surface expression of CD271 was lower than that of EGFR. This is the first study to demonstrate the efficacy of CD271-targeted NIR-PIT, which we believe will have a significant impact on the future development of cancer stem cell-targeted therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsImmunotherapyReceptors, Nerve Growth FactorHead and Neck NeoplasmsPhototherapyHumansAnimalsMiceCell Line, TumorXenograft Model Antitumor AssaysInfrared RaysFemaleNerve Tissue Proteins

Stichwörter der Autor:innen

HPCM2IR700NHS esteralluminoxantibody-drug conjugate

Substanzen

Receptors, Nerve Growth FactorNGFR protein, humanNerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Head and Neck Surgery, Institute of Science Tokyo, Tokyo 113-8519, Japan.
  • Department of Dental Radiology and Radiation Oncology, Institute of Science Tokyo, Tokyo 113-8519, Japan.
  • Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States.
  • Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, 47-1 Nodayama, Medeshima-Shiote, Natori, Miyagi 981-1293, Japan.

ORCID-Profile: Ryosuke Takahashi, Hisataka Kobayashi, Ryuhei Okada

Förderung

  • Intramural Research Program
  • Japan Society for the Promotion of Science

Zitieren

APA

Takahashi, R., Kaida, A., Nojima, H., Okuyama, S., Mochizuki, M., Morita, S., Tamai, K., Miura, M., Kobayashi, H., Asakage, T., & Okada, R. (2025). CD271 Targeted Near-Infrared Photoimmunotherapy for Local Depletion of Cancer Stem Cells. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01157

Vancouver

Takahashi R, Kaida A, Nojima H, Okuyama S, Mochizuki M, Morita S, et al. CD271 Targeted Near-Infrared Photoimmunotherapy for Local Depletion of Cancer Stem Cells. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c01157

BibTeX
@article{Takahashi2025,
  author = {Takahashi, Ryosuke and Kaida, Atsushi and Nojima, Hitomi and Okuyama, Shuhei and Mochizuki, Mai and Morita, Shinkichi and Tamai, Keiichi and Miura, Masahiko and Kobayashi, Hisataka and Asakage, Takahiro and Okada, Ryuhei},
  title = {CD271 Targeted Near-Infrared Photoimmunotherapy for Local Depletion of Cancer Stem Cells},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c01157}
}
Kostenlos starten →